For: | Acharya S, Lama S, Kanigicherla DA. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection. World J Transplant 2023; 13(6): 299-308 [PMID: 38174145 DOI: 10.5500/wjt.v13.i6.299] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v13/i6/299.htm |
Number | Citing Articles |
1 |
Lukas K. van Vugt, Erzsi Tegzess, Marieke van der Zwan, Marian C. Clahsen‐van Groningen, Brenda C. M. de Winter, Priya Vart, Marlies E. J. Reinders, Jan Stephan F. Sanders, Stefan P. Berger, Dennis A. Hesselink. Multicenter, Real‐World Clinical Evaluation of Alemtuzumab and Anti‐Thymocyte Globulin for Severe Acute T Cell‐Mediated Kidney Transplant Rejection. Clinical Transplantation 2024; 38(12) doi: 10.1111/ctr.70046
|
2 |
Andreea Grosu-Bularda, Florin-Vlad Hodea, Dragos Zamfirescu, Alexandru Stoian, Răzvan Nicolae Teodoreanu, Ioan Lascăr, Cristian Sorin Hariga. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?. Journal of Personalized Medicine 2024; 14(3): 322 doi: 10.3390/jpm14030322
|